article · PubMed
Payment for the management of hepatitis C patients is predominantly out-of-pocket, and a significant proportion of households suffer financial catastrophe because of the cost of managing HCV. Coordinated efforts by stakeholders are required to implement prepayment schemes and direct subsidies to enhance financial protection for patients managed for HCV infection.
This page summarises published work. The authoritative version sits with the publisher.
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
